Crest Clinical Study Supports Triclosan Antigingivitis Efficacy – Ciba
This article was originally published in The Tan Sheet
Executive Summary
A clinical trial conducted in China on a triclosan-containing toothpaste marketed under the Crest brand demonstrates an improvement in the bleeding index of subjects, supporting the ingredient's antigingivitis efficacy, Ciba states in an Oct. 1 1submission to FDA.
You may also be interested in...
Triclosan Antigingivitis Effectiveness Data Questioned by P&G, Colgate
Procter & Gamble and Colgate object to the inclusion of triclosan as a Category I ingredient in the antigingivitis monograph as proposed by triclosan producer Ciba
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC